Vitamin C in Skincare
Vitamin C — L-ascorbic acid — is one of the most extensively studied and most prescribed actives in skincare. It is present in high concentrations in normal healthy skin, where it plays critical roles in collagen synthesis, antioxidant protection, and pigmentation control. The clinical evidence is well-established. The formulation problem is equally well-established: ascorbic acid is inherently unstable in water, and a formulation that has oxidised cannot deliver the benefits the evidence supports. This page covers what the current clinical literature shows about topical vitamin C in skincare, why the instability problem limits conventional formulations, and how the EVIK™ LyoPearl freeze-dried bead format addresses that limitation directly.Looking for the product specification, formula, and sample request?What the Clinical Evidence Shows
Published systematic reviews and clinical trials identify four primary mechanisms of action relevant to topical ascorbic acid in skincare:
1. Collagen synthesis and structural support
Ascorbic acid acts as a required cofactor for prolyl and lysyl hydroxylase, the enzymes responsible for hydroxylating proline and lysine residues during collagen biosynthesis. Without adequate ascorbic acid, collagen fibrils cannot be properly cross-linked and stabilised. Clinical studies have shown that topical ascorbic acid increases collagen synthesis at the dermal–epidermal junction, promotes activation of dermal elastic fibre synthesis, and reduces collagen degradation — collectively supporting skin firmness, elasticity, and reduction of fine lines and wrinkles. (Correia et al., Journal of Cosmetic Dermatology, 2023; Pullar et al., Nutrients, 2017.)
2. Antioxidant protection and photoprotection
As one of the most potent antioxidants in human skin, ascorbic acid neutralises reactive oxygen species (ROS) generated by UV radiation, pollution, and other environmental stressors. It acts as the primary replenisher of vitamin E in the skin's antioxidant network, protecting cell membranes from lipid peroxidation. Multiple controlled clinical studies have demonstrated that topical ascorbic acid reduces UV-induced photodamage, attenuates erythema and UV-induced immunosuppression, and provides measurable photoprotection against photocarcinogenesis. (Pinnell et al., Dermatol Surg, 2001; Lin et al., J Am Acad Dermatol, 2003; Sasidharan et al., 2023.)
3. Skin brightening and antipigmentary effect
Ascorbic acid inhibits melanin biosynthesis by downregulating the monophenolase activity of tyrosinase — the rate-limiting enzyme in the melanin synthesis pathway. Clinical studies in patients with melasma and photodamage have demonstrated measurable reductions in pigmentation and improvements in skin tone. A 2023 systematic review across three randomised controlled trials confirmed that topical ascorbic acid produces smoother, less wrinkled skin with improved evenness compared to placebo. (Correia et al., Journal of Cosmetic Dermatology, 2023.)
4. The formulation challenge — why potency at delivery determines efficacy
The clinical efficacy of ascorbic acid is well-established, but current evidence confirms that outcomes hinge critically on formulation stability rather than labelled concentration. L-ascorbic acid oxidises rapidly in aqueous solution upon exposure to light, air, and alkaline pH — converting to dehydroascorbic acid and then to inactive degradation products. A 2024 systematic review concluded that clinical outcomes with vitamin C depend primarily on formulation stability and that ascorbate concentration alone does not predict efficacy. A formulation that has oxidised cannot deliver the collagen synthesis, photoprotection, or brightening benefits the literature supports, regardless of what the label states. (JCAD Clinical Applications of Vitamin C in Dermatology, 2024.)
The Stability Problem in Conventional Vitamin C Skincare
Water is the primary driver of ascorbic acid oxidation. In conventional liquid serum formulations, the ascorbic acid is dissolved in water from the moment of manufacture. The clock on oxidation starts at filling — before the product reaches the consumer, before the bottle is opened, and before the first application.
Once opened, the degradation accelerates. Every time the consumer opens the bottle, oxygen enters. Every exposure to light contributes. Every contact with the skin's mildly alkaline surface chemistry drives the pH of the residual formula upward, accelerating oxidation further. Studies tracking ascorbic acid concentration in opened serum formulations have shown significant potency loss within days to weeks of first use — well before the bottle is empty.
Conventional formulation strategies attempt to slow this process: pH adjustment to below 3.5, addition of ferulic acid and tocopherol as stabilisers, opaque packaging to limit light exposure, airless pump dispensers to reduce oxygen exposure. Each measure extends stability but none eliminates the fundamental instability of dissolved ascorbic acid in water. The problem is compounded in premium and clean-beauty formulations, where the preservative systems, chelators, and antioxidant stabilisers required to keep an aqueous vitamin C formula stable across its shelf life add label complexity that conflicts with preservative-free and natural positioning.
Why the Freeze-Dried Bead Format Changes the Picture
The core insight behind EVIK™ LyoPearl Ascorbic Acid is straightforward: remove the water, and the oxidation stops. Lyophilization — freeze-drying — removes water from the formulation under controlled conditions without the thermal damage that conventional drying would cause. The result is a dry, stable bead in which the L-ascorbic acid is held in its reduced, biologically active form, sealed against moisture, light, and oxygen.Because each EVIK™ LyoPearl bead is a single-dose unit, the active is never exposed to water until the moment of application. There is no oxidation during manufacture, no oxidation during shipping or storage, and no accumulated degradation from repeated opening. The consumer dissolves one bead onto damp skin at the moment of use and applies a freshly prepared, full-potency dose of ascorbic acid — every time.This changes what is achievable in skincare formulation:• No preservatives. Without water there is nothing to support microbial growth, eliminating the preservative system from the formula entirely.
• No antioxidant stabiliser required. Ferulic acid and tocopherol are used in liquid formulations to slow ascorbic acid oxidation; in a dry bead, the oxidation mechanism itself is removed.
• Ambient temperature storage. No refrigeration, no cold chain, no temperature-controlled distribution.
• Guaranteed potency at application. The ascorbic acid concentration in the bead at the moment of dissolution is the concentration the consumer receives, not the concentration after weeks of oxidation in an opened bottle.
• Clean label. The formula contains active ingredients and the lyophilization matrix, not a stack of stability-support ingredients required to keep liquid ascorbic acid viable.
Skincare Use Cases and Formulation Applications
For skincare brands, product developers, and formulation scientists, the EVIK™ LyoPearl Ascorbic Acid bead opens product concepts that conventional aqueous vitamin C formulations cannot support reliably:• Premium single-use vitamin C serum — each bead dissolved by the consumer at point of use delivers a clinically meaningful, full-potency dose of L-ascorbic acid without the potency decline inherent in multi-use liquid serums.• Two-component vitamin C system — bead paired with a liquid activator (water, hyaluronic acid serum, botanical water) in dual-chamber or ampoule packaging — the active is never exposed to water until use.• Preservative-free and clean-beauty vitamin C — eliminates the preservative and stabiliser load required in aqueous formulations; suitable for products positioned on free-from, natural, or waterless credentials.• Anti-aging and brightening treatment formats — high-concentration L-ascorbic acid (82.7% dry weight) with sodium hyaluronate and collagen peptides in a targeted single-dose treatment format.• Travel and sample-size vitamin C — dry bead format requires no liquid volume declaration for air travel, no refrigeration, and no compromised potency from transit.• Stability benchmarking and comparative evaluation — for research teams comparing potency retention of lyophilized versus aqueous ascorbic acid formulations over time.EVIK™ LyoPearl Ascorbic Acid
EVIK™ LyoPearl Ascorbic Acid is available for research and evaluation. Each bead contains 4.2 mg of the formula described above — 82.7% L-ascorbic acid dry weight with sodium hyaluronate and hydrolyzed collagen co-actives. Supplied as 10 LyoPearls per vial.• → View product specifications, formula, and use instructions• → Request a sample or contact our team• → Custom lyobead formulation servicesEVIK™ LyoPearl Ascorbic Acid is part of the EVIK™ LyoPearl range of freeze-dried skincare lyobeads, developed by Evik Diagnostics — built on 15 years of freeze-dry bead expertise across diagnostics and life sciences.